Randomized Double Blind Placebo Control Study in Patients With Schizophrenia
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Randomized Double Blind Placebo Control Study in Patients With Schizophrenia is a clinical trial[1].
Key Facts
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia is in the country of Pakistan[2].
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia's instance of is recorded as clinical trial[3].
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia's start time is recorded as +2010-08-31T00:00:00Z[4].
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia's end time is recorded as +2013-06-30T00:00:00Z[5].
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia's main subject is recorded as schizophrenia[6].
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia's number of participants is recorded as {'unit': '1', 'amount': '+303'}[7].
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia's title is recorded as Randomized Double Blind Placebo Controlled Study of Ondansetron and Simvastatis Added to Treatment as Usual in Patients With Schizophrenia[8].
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia's short name is recorded as ROSES[9].
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia's ClinicalTrials.gov ID is recorded as NCT01602029[11].
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}[12].
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia's research intervention is recorded as ondansetron[13].
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia's clinical trial phase is recorded as phase II clinical trial[14].
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia's research site is recorded as Abbasi Shaheed Hospital[15].
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia's research site is recorded as Dow University of Health Sciences[16].
- Randomized Double Blind Placebo Control Study in Patients With Schizophrenia's study type is recorded as interventional study[17].